Compare Kowa Co. Ltd. (Osaka) with Similar Stocks
Dashboard
1
With a growth in Net Profit of 90.86%, the company declared Very Positive results in May 26
- DEBT-EQUITY RATIO (HY) Lowest at -58.98 %
- INTEREST COVERAGE RATIO(Q) Highest at 20,026.23
- RAW MATERIAL COST(Y) Fallen by -3.71% (YoY)
2
With ROE of 12.90%, it has a attractive valuation with a 1.19 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
JPY 4,388 Million (Micro Cap)
9.00
NA
0.00%
-0.63
14.33%
1.21
Revenue and Profits:
Net Sales:
1,799 Million
(Quarterly Results - May 2026)
Net Profit:
200 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.35%
0%
0.35%
6 Months
-11.52%
0%
-11.52%
1 Year
-33.85%
0%
-33.85%
2 Years
-5.39%
0%
-5.39%
3 Years
30.3%
0%
30.3%
4 Years
-4.44%
0%
-4.44%
5 Years
-4.55%
0%
-4.55%
Kowa Co. Ltd. (Osaka) for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.02%
EBIT Growth (5y)
15.18%
EBIT to Interest (avg)
51.76
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
1.92
Tax Ratio
30.55%
Dividend Payout Ratio
12.63%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
41.24%
ROE (avg)
24.44%
Valuation key factors
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
1.19
EV to EBIT
2.82
EV to EBITDA
2.15
EV to Capital Employed
1.43
EV to Sales
0.33
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
50.86%
ROE (Latest)
12.90%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - May'26 - QoQ
May'26
Nov'25
Change(%)
Net Sales
1,799.20
1,558.20
15.47%
Operating Profit (PBDIT) excl Other Income
351.30
197.00
78.32%
Interest
1.80
1.80
Exceptional Items
0.00
4.10
-100.00%
Consolidate Net Profit
199.50
90.30
120.93%
Operating Profit Margin (Excl OI)
175.90%
119.20%
5.67%
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Consolidated) - Feb'26
Feb'26
Feb'25
Change(%)
Net Sales
6,394.40
6,368.50
0.41%
Operating Profit (PBDIT) excl Other Income
978.10
1,024.30
-4.51%
Interest
10.60
15.70
-32.48%
Exceptional Items
0.00
43.00
-100.00%
Consolidate Net Profit
444.70
633.70
-29.82%
Operating Profit Margin (Excl OI)
116.90%
125.20%
-0.83%
USD in Million.
Net Sales
YoY Growth in year ended Feb 2026 is 0.41% vs -0.55% in Feb 2025
Consolidated Net Profit
YoY Growth in year ended Feb 2026 is -29.82% vs -12.35% in Feb 2025
About Kowa Co. Ltd. (Osaka) 
Kowa Co. Ltd. (Osaka)
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






